1. A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS5. Issue 2 (16th May 2022) Authors: Watanabe, Motoki; Boku, Shogen; Kobayashi, Kaito; Kurumida, Yoichi; Sukeno, Mamiko; Masuda, Mitsuharu; Mizushima, Katsura; Kato, Chikage; Iizumi, Yosuke; Hirota, Kiichi; Naito, Yuji; Mutoh, Michihiro; Kameda, Tomoshi; Sakai, Toshiyuki Editors: Nelson, Karen E Journal: PNAS nexus Issue: Volume 1:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma. (1st September 2018) Authors: Hagiwara, Nobuhisa; Watanabe, Motoki; Iizuka-Ohashi, Mahiro; Yokota, Isao; Toriyama, Seijiro; Sukeno, Mamiko; Tomosugi, Mitsuhiro; Sowa, Yoshihiro; Hongo, Fumiya; Mikami, Kazuya; Soh, Jintetsu; Fujito, Akira; Miyashita, Hiroaki; Morioka, Yukako; Miki, Tsuneharu; Ukimura, Osamu; Sakai, Toshiyuki Journal: Cancer letters Issue: Volume 431(2018) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)‐reactivating agents enhance efficacy of 5‐fluorouracil on human colon cancer cells. Issue 6 (3rd April 2013) Authors: Watanabe, Motoki; Sowa, Yoshihiro; Yogosawa, Mayumi; Sakai, Toshiyuki Journal: Cancer science Issue: Volume 104:Issue 6(2013:Jun.) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗